Detalhe da pesquisa
1.
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19.
Am J Respir Crit Care Med
; 207(3): 261-270, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099435
2.
A Multidimensional Bioinformatic Platform for the Study of Human Response to Surgery.
Ann Surg
; 275(6): 1094-1102, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35258509
3.
Small bowel and abdominal wall transplantation: A novel technique for synchronous revascularization.
Am J Transplant
; 19(7): 2122-2126, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30913367
4.
Radiolabeled Biodistribution of Expansile Nanoparticles: Intraperitoneal Administration Results in Tumor Specific Accumulation.
ACS Nano
; 17(3): 2212-2221, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36701244
5.
Pilot-scale production of expansile nanoparticles: Practical methods for clinical scale-up.
J Control Release
; 337: 144-154, 2021 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34280414
6.
Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium.
J Cancer
; 10(15): 3344-3351, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31293637
7.
Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
Mol Pharmacol
; 73(2): 338-48, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17975007
8.
Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models.
Clin Cancer Res
; 12(5): 1606-14, 2006 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16533788
9.
The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases.
Cancer Res
; 65(19): 9038-46, 2005 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16204078
10.
Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents.
J Med Chem
; 47(22): 5367-80, 2004 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-15481975
11.
GEM 231, a second-generation antisense agent complementary to protein kinase A RIalpha subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts.
Int J Oncol
; 21(1): 65-72, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12063551
12.
Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models.
Cancer Chemother Pharmacol
; 67(6): 1415-22, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20809121
13.
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies.
Alzheimers Res Ther
; 3(5): 28, 2011 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21943025
14.
Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy.
Clin Cancer Res
; 16(15): 3887-900, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20554752
15.
Preclinical activity of an i.v. formulation of rubitecan in IDD-P against human solid tumor xenografts.
Anticancer Drugs
; 13(9): 965-75, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12394260
16.
A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models.
Mol Pharmacol
; 66(3): 635-47, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15322256